Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29Pain, Postoperative 10Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Melanoma 5Ovarian Neoplasms 4Hemorrhage 4Head and Neck Neoplasms 4Agnosia 4Rectal Neoplasms 3Neurotoxicity Syndromes 3Nasopharyngeal Carcinoma 3Myoma 3Multiple Endocrine Neoplasia Type 1 3Meningioma 3Lymphoma, Non-Hodgkin 3Leiomyoma 3Glioblastoma 3Delirium 3Colonic Neoplasms 3Chronic Pain 3Warts 2Uterine Cervical Neoplasms 2Stomatitis 2Skin Neoplasms 2

Interventions

Exercise 5Vitamin D 3Resistance Training 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Oxycodone 2Omeprazole 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Dexmedetomidine 2Blood Specimen Collection 2Aspirin 2ziprasidone 1soybean oil, phospholipid emulsion 1semaglutide 1montelukast 1microcrystalline cellulose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Inflammation × Sodium Chloride × Clear all
NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed
10 enrolled

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡